s6y
Company name or ticker
Search
Spyre Therapeutics, Inc.
DEF 14A
Definitive proxy statements
Filed
Friday, April 21, 2017
Period
Jun 7, 2017
Accession number
0001564590-17-006805
Documents
DEF 14A
DEF 14A
On sec.gov
Filing index
All files
Complete submission text
SGML header